[en] It is now well accepted that inflammatory events contribute to the pathogenesis of numerous neurological disorders, including multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease, and AID's dementia. Whereas inflammation in the periphery is subject to rapid down regulation by increases in anti-inflammatory molecules and the presence of scavenging soluble cytokine receptors, the presence of an intact blood-brain barrier may limit a similar autoregulation from occurring in brain. Mechanisms intrinsic to the brain may provide additional immunomodulatory functions, and whose dysregulation could contribute to increased inflammation in disease. The findings that noradrenaline (NA) reduces cytokine expression in microglial, astroglial, and brain endothelial cells in vitro, and that modification of the noradrenergic signaling system occurs in some brain diseases having an inflammatory component, suggests that NA could act as an endogenous immunomodulator in brain. Furthermore, accumulating studies indicate that modification of the noradrenergic signaling system occurs in some neurodiseases. In this article, we will briefly review the evidence that NA can modulate inflammatory gene expression in vitro, summarize data supporting a similar immunomodulatory role in brain, and present recent data implicating a role for NA in attenuating the cortical inflammatory response to beta amyloid protein.
Disciplines :
Neurology
Author, co-author :
Feinstein, Douglas L; Department of Anesthesiology, University of Illinois, Chicago, IL, USA. dlfeins@uic.edu
HENEKA, Michael ; Department of Neurology, University of Bonn, Bonn, Germany
Gavrilyuk, Vitaliy; Department of Anesthesiology, University of Illinois, Chicago, IL, United States
Dello Russo, Cinzia; Department of Anesthesiology, University of Illinois, Chicago, IL, United States
Weinberg, Guy; Department of Anesthesiology, University of Illinois, Chicago, IL, United States
Galea, Elena; Department of Anesthesiology, University of Illinois, Chicago, IL, United States
External co-authors :
yes
Language :
English
Title :
Noradrenergic regulation of inflammatory gene expression in brain.
Adolfsson R., Gottfries C.G., Roos B.E., Winblad B. (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br. J. Psychiatry 135:216-223.
Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21:383-421.
Akiyama H., Kawamata T., Yamada T., Tooyama I., Ishii T., McGeer P.L. (1993) Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer's disease and some other degenerative neurological disorders. Acta Neuropathol. (Berlin) 85:628-634.
Arenzana-Seisdedos F., Thompson J., Rodriguez M.S., Bachelerie F., Thomas D., Hay R.T. (1995) Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF kappa B. Mol. Cell Biol. 15:2689-2696.
Asensio V.C., Campbell I.L. (2001) Chemokines and viral diseases of the central nervous system. Adv. Virus Res. 56:127-173.
Ballestas M.E., Benveniste E.N. (1997) Elevation of cyclic AMP levels in astrocytes antagonizes cytokine-induced adhesion molecule expression. J. Neurochem. 69:1438-1448.
Balyasnikova I.V., Pelligrino D.A., Greenwood J., Adamson P., Dragon S., Raza H., Galea E. (2000) Cyclic adenosine monophosphate regulates the expression of the intercellular adhesion molecule and the inducible nitric oxide synthase in brain endothelial cells. J. Cereb. Blood Flow Metab. 20:688-699.
Basta P.V., Moore T.L., Yokota S., Ting J.P. (1989) A beta-adrenergic agonist modulates DR alpha gene transcription via enhanced cAMP levels in a glioblastoma multiforme line. J. Immunol. 142:2895-2901.
Benveniste E.N., Huneycutt B.S., Shrikant P., Ballestas M.E. (1995) Second messenger systems in the regulation of cytokines and adhesion molecules in the central nervous system. Brain Behav. Immunol. 9:304-314.
Benveniste E.N., Nguyen V.T., O'Keefe G.M. (2001) Immunological aspects of microglia: Relevance to Alzheimer's disease. Neurochem. Int. 39:381-391.
Birch R.E., Polmar S.H. (1986) Adenosine-induced immunosuppression: The role of the adenosine receptor - Adenylate cyclase interaction in the alteration of T-lymphocyte surface phenotype and immunoregulatory function. Int. J. Immunopharmacol. 8:329-337.
Bourdoulous S., Durieu-Trautmann O., Strosberg A.D., Couraud P.O. (1993) Catecholamines stimulate MHC class I, class II, and invariant chain gene expression in brain endothelium through different mechanisms. J. Immunol. 150:1486-1495.
Burgher K.L., Heroux J.A., Ringheim G.E. (1997) Cyclic AMP potentiation of cytokine-induced nitric oxide synthase activity in a murine astrocyte cell line. Neurochem. Int. 30:483-489.
Caggiano A.O., Kraig R.P. (1999) Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J. Neurochem. 72:565-575.
Cannella B., Raine C.S. (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:424-435.
Chelmicka-Schorr E., Kwasniewski M.N., Thomas B.E., Arnason B.G. (1989) The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 25:203-207.
Cho S., Kim Y., Cruz M.O., Park E.M., Chu C.K., Song G.Y., Joh T.H. (2001) Repression of proinflammatory cytokine and inducible nitric oxide synthase (NOS2) gene expression in activated microglia by N-acetyl-O-methyldopamine: Protein kinase A-dependent mechanism. GLIA 33:324-333.
Chopp M., Li Y., Jiang N., Zhang R.L., Prostak J. (1996) Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J. Cereb. Blood Flow Metab. 16:578-584.
Cohen Z., Bonvento G., Lacombe P., Hamel E. (1996) Serotonin in the regulation of brain microcirculation. Prog. Neurobiol. 50:335-362.
Cohen Z., Ehret M., Maitre M., Hamel E. (1995) Ultrastructural analysis of tryptophan hydroxylase immunoreactive nerve terminals in the rat cerebral cortex and hippocampus: Their associations with local blood vessels. Neuroscience 66:555-569.
Cohen Z., Molinatti G., Hamel E. (1997) Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. J. Cereb. Blood Flow Metab. 17:894-904.
Coutinho G.C., Durieu-Trautmann O., Strosberg A.D., Couraud P.O. (1991) Catecholamines stimulate the IFN-gamma-induced class II MHC expression on bovine brain capillary endothelial cells. J. Immunol. 147:2525-2529.
Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:2684-2690.
De Keyser J., Wilczak N., Leta R., Streetland C. (1999) Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology 53:1628-1633.
Degroot C.J.A., Ruuls S.R., Theeuwes J.W.M., Dijkstra C.D., Vandervalk P. (1997) Astrocytes brain, human macrophages, immunocytochemistry, macrophage, isolation, nitric oxide synthase, and spinal cord. immunocytochemical characterizatoinof the expression of the inducibale and constitutive isoforms of nitric oxide synthase in demyelinating mulitiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56:10-20.
Delgado M., Ganea D. (2000) Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. J. Immunol. 165:3051-3057.
Dinter H., Onuffer J., Faulds D., Perez H.D. (1997) Phosphodiesterase type IV inhibitors in the treatment of multiple sclerosis. J. Mol. Med. 75:95-102.
Elenkov I.J., Hasko G., Kovacs K.J., Vizi E.S. (1995) Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J. Neuroimmunol. 61:123-131.
Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. (2000) The sympathetic nerve - An integrative interface between two supersystems: The brain and the immune system. Pharmacol. Rev. 52:595-638.
Endoh M., Maiese K., Pulsinelli W.A., Wagner J.A. (1993) Reactive astrocytes express NADPH diaphorase in vivo after transient ischemia. Neurosci. Lett. 154:125-128.
Etienne-Manneville S., Chaverot N., Strosberg A.D., Couraud P.O. (1999) ICAM-1-coupled signaling pathways in astrocytes converge to cyclic AMP response element-binding protein phosphorylation and TNF-alpha secretion. J. Immunol. 163:668-674.
Farmer P., Pugin J. (2000) Beta-adrenergic agonists exert their anti-inflammatory effects in monocytic cells through the I kappa B/NF kappa B pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 279.
Feinstein D.L. (1998) Suppression of astroglial nitric oxide synthase expression by norepinephrine results from decreased NOS2 promoter activity. J. Neurochem. 70:1484-1496.
Feinstein D.L., Galea E., Reis D.J. (1993) Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J. Neurochem. 60:1945-1948.
Folcik V.A., Smith T., O'Bryant S., Kawczak J.A., Zhu B., Sakurai H., Kajiwara A., Staddon J.M., Glabinski A., Chernosky A.L., Tani M., Johnson J.M., Tuohy V.K., Rubin L.L., Ransohoff R.M. (1999) Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: An additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors. J. Neuroimmunol. 97:119-128.
Forno L.S., Barbour P.J., Norville R.L. (1978) Presenile dementia with Lewy bodies and neurofibrillary tangles. Arch. Neurol. 35:818-822.
Freedman R., Foote S.L., Bloom F.E. (1975) Histochemical characterization of a neocortical projection of the nucleus locus coeruleus in the squirrel monkey. J. Comparative Neurol. 164:209-231.
Fritschy J.M., Grzanna R. (1991) Experimentally-induced neuron loss in the locus coeruleus of adult rats. Exp. Neurol. 111:123-127.
Frohman E.M., Frohman T.C., Dustin M.L., Vayuvegula B., Choi B., Gupta A., Van den N.S., Gupta S. (1989) The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: Relevance to intracerebral antigen presentation. J. Neuroimmunol. 23:117-124.
Frohman E.M., Vayuvegula B., Gupta S., Van den N.S. (1988) Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms. Proc. Natl. Acad. Sci. U.S.A. 85:1292-1296.
Frohman E.M., Vayuvegula B., Van den N.S., Gupta S. (1988) Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes. J. Neuroimmunol. 17:89-101.
Galea E., Feinstein D.L. (1999) Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J. 13:2125-2137.
Galea E., Feinstein D.L., Reis D.J. (1992) Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl. Acad. Sci. U.S.A. 89:10945-10949.
Gavrilyuk V., Horvath P., Weinberg G., Feinstein D.L. (2001) A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells. J. Neurochem. 78:129-140.
Genain C.P., Roberts T., Davis R.L., Nguyen M.H., Uccelli A., Faulds D., Li Y., Hedgpeth J., Hauser S.L. (1995) Prevention of autoimmune demyelination in non-human primates by a camp-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 92:3601-3605.
German D.C., Manaye K.F., White C.L. III, Woodward D.J., McIntire D.D., Smith W.K., Kalaria R.N., Mann D.M. (1992) Disease-specific patterns of locus coeruleus cell loss. Ann. Neurol. 32:667-676.
Ghersa P., Hooft V.H., Whelan J., Cambet Y., Pescini R., DeLamarter J.F. (1994) Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J. Biol. Chem. 269:29129-29137.
Griffin W.S., Sheng J.G., Roberts G.W., Mrak R.E. (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54:276-281.
Hasko G. (2001) Receptor-mediated interaction between the sympathetic nervous system and immune system in inflammation. Neurochem. Res. 26:1039-1044.
Hasko G., Shanley T.P., Egnaczyk G., Nemeth Z.H., Salzman A.L., Vizi E.S., Szabo C. (1998) Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism. Br. J. Pharmacol. 125:1297-1303.
Hellendall R.P., Ting J.P. (1997) Differential regulation of cytokine-induced major histocompatibility complex class II expression and nitric oxide release in rat microglia and astrocytes by effectors of tyrosine kinase, protein kinase C, and cAMP. J. Neuroimmunol. 74:19-29.
Heneka M.T., Feinstein D.L. (2001) Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 114:8-18.
Heneka M.T., Feinstein D.L., Galea E., Gleichmann M., Wullner U., Klockgether T. (1999) Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. J. Neuroimmunol. 100:156-168.
Heneka M.T., Klockgether T., Feinstein D.L. (2000) Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J. Neurosci. 20:6862-6867.
Heneka M.T., Wiesinger H., Dumitrescu-Ozimek L., Riederer P., Feinstein D.L., Klockgether T. (2001) Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 60:906-916.
Hetier E., Ayala J., Bousseau A., Prochiantz A. (1991) Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cells. Exp. Brain Res. 86:407-413.
Iadecola C. (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:132-139.
Iversen L.L., Rossor M.N., Reynolds G.P., Hills R., Roth M., Mountjoy C.Q., Foote S.L., Morrison J.H., Bloom F.E. (1983) Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type. Neurosci. Lett. 39:95-100.
Jander S., Kraemer M., Schroeter M., Witte O.W., Stoll G. (1995) Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J. Cereb. Blood Flow Metab. 15:42-51.
Jovanova-Nesic K., Nikolic V., Jankovic B.D. (1993) Locus ceruleus and immunity. Part II. Suppression of experimental allergic encephalomyelitis and hypersensitivity skin reactions in rats with lesioned locus ceruleus. Int. J. Neurosci. 68:289-294.
Ju W.K., Park K.J., Choi E.K., Kim J., Carp R.I., Wisniewski H.M., Kim Y.S. (1998) Expression of inducible nitric oxide synthase in the brains of scrapie-infected mice. J. Neurovirol. 4:445-450.
Kalaria R.N., Stockmeier C.A., Harik S.I. (1989) Brain microvessels are innervated by locus ceruleus noradrenergic neurons. Neurosci. Lett. 97:203-208.
Karpus W.J., Konkol R.J., Killen J.A. (1988) Central catecholamine neurotoxin administration. Part 1. Immunological changes associated with the suppression of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 18:61-73.
Kim J.S. (1996) Cytokines and adhesion molecules in stroke and related diseases. J. Neurol. Sci. 137:69-78.
Konkol R.J., Wesselmann U., Karpus W.J., Leo G.L., Killen J.A., Roerig D.L. (1990) Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine. J. Neuroimmunol. 26:25-34.
Lassmann H., Zimprich F., Rossler K., Vass K. (1991) Inflammation in the nervous system. Basic mechanisms and immunological concepts. Rev. Neurol. (Paris) 147:763-781.
Lee S.C., Collins M., Vanguri P., Shin M.L. (1992) Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia. J. Immunol. 148:3391-3397.
Lee S.C., Zhao M.L., Hirano A., Dickson D.W. (1999) Inducible nitric oxide synthase immunoreactivity in the Alzheimer's disease hippocampus: Association with Hirano bodies, neurofibrillary tangles, and senile plaques. J. Neuropathol. Exp. Neurol. 58:1163-1169.
Lee S.J., Benveniste E.N. (1999) Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 98:77-88.
Lee S.J., Drabik K., Van Wagoner N.J., Lee S., Choi C., Dong Y., Benveniste E.N. (2000) ICAM-1-induced expression of proinflammatory cytokines in astrocytes: Involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. J. Immunol. 165:4658-4666.
Loughlin A.J., Woodroofe M.N., Cuzner M.L. (1993) Modulation of interferon-gamma-induced major histocompatibility complex class II and Fc receptor expression on isolated microglia by transforming growth factor-beta 1, interleukin-4, noradrenaline and glucocorticoids. Immunology 79:125-130.
Magnuson D.S., Staines W.A., Marshall K.C. (1993) Electrophysiological changes accompanying DSP4 lesions of rat locus coeruleus neurons. Brain Res. 628:317-320.
Mann D.M., Yates P.O., Hawkes J. (1983) The pathology of the human locus ceruleus. Clin. Neuropathol. 2:1-7.
Manna S.K., Aggarwal B.B. (1998) Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF kappa B activation induced by various inflammatory agents. J. Immunol. 161:2873-2880.
Marcyniuk B., Mann D.M., Yates P.O. (1986) Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged. Neurosci. Lett. 64:247-252.
Mattson M.P., Duan W., Pedersen W.A., Culmsee C. (2001) Neurodegenerative disorders and ischemic brain diseases. Apoptosis 6:69-81.
Mavridis M., Degryse A.D., Lategan A.J., Marien M.R., Colpaert F.C. (1991) Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: A possible role for the locus coeruleus in the progression of Parkinson's disease. Neuroscience 41:507-523.
Mehlhorn G., Hollborn M., Schliebs R. (2000) Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int. J. Dev. Neurosci. 18:423-431.
Minghetti L., Nicolini A., Polazzi E., Creminon C., Maclouf J., Levi G. (1997) Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. GLIA 19:152-160.
Morrissey S.P., Deichmann R., Syha J., Simonis C., Zettl U., Archelos J.J., Jung S., Stodal H., Lassmann H., Toyka K.V., Haase A., Hartung H.P. (1996) Partial inhibition of AT-EAE by an antibody to ICAM-1: Clinico-histological and MRI studies. J. Neuroimmunol. 69:85-93.
Nishino K., Lin C.S., Morse J.K., Davis J.N. (1991) DSP4 treatment worsens hippocampal pyramidal cell damage after transient ischemia. Neuroscience 43:361-367.
Oda H., Murayama T., Nomura Y. (1997) Inhibition of inducible nitric oxide synthase expression by endothelin in rat glial cells prepared from the neonatal rat brain. J. Neurochem. 69:669-674.
Ohara Y., McCarron R.M., Hoffman T.T., Sugano H., Bembry J., Lenz F.A., Spatz M. (2000) Adrenergic mediation of TNF alpha-stimulated ICAM-1 expression on human brain microvascular endothelial cells. Acta Neurochir Suppl. 76:117-120.
Oleszak E.L., Zaczynska E., Bhattacharjee M., Butunoi C., Legido A., Katsetos C.D. (1998) Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis. Clin. Diagnos. Lab. Immunol. 5:438-445.
Olpe H.R., Laszlo J., Dooley D.J., Heid J., Steinmann M.W. (1983) Decreased activity of locus coeruleus neurons in the rat after DSP-4 treatment. Neurosci. Lett. 40:81-84.
Pahan K., Namboodiri A.M., Sheikh F.G., Smith B.T., Singh I. (1997) Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 272:7786-7791.
Paspalas C.D., Papadopoulos G.C. (1998) Ultrastructural evidence for combined action of noradrenaline and vasoactive intestinal polypeptide upon neurons, astrocytes, and blood vessels of the rat cerebral cortex. Brain Res. Bull. 45:247-259.
Petrova T.V., Akama K.T., Van Eldik L.J. (1999) Selective modulation of BV-2 microglial activation by prostaglandin E(2). Differential effects on endotoxin-stimulated cytokine induction. J. Biol. Chem. 274:28823-28827.
Prinz M., Hausler K.G., Kettenmann H., Hanisch U. (2001) Beta-adrenergic receptor stimulation selectively inhibits IL-12p40 release in microglia(1). Brain Res. 899:264-270.
Rothwell N.J., Luheshi G.N. (2000) Interleukin 1 in the brain: Biology, pathology and therapeutic target. Trends Neurosci. 23:618-625.
Rott O., Cash E., Fleischer B. (1993) Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1, but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immunol. 23:1745-1751.
Rozemuller J.M., Eikelenboom P., Pals S.T., Stam F.C. (1989) Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci. Lett. 101:288-292.
Ruuls S.R., Van Der Linden S., Sontrop K., Huitinga I., Dijkstra C.D. (1996) Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:467-474.
Satoh J., Kim S.U., Kastrukoff L.F., Takei F. (1991) Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes. J. Neurosci. Res. 29:1-12.
Scheibel A.B., Duong T.H., Tomiyasu U. (1987) Denervation microangiopathy in senile dementia: Alzheimer type. Alzheimer's Dis. Assoc. Disord. 1:19-37.
Shrikant P., Lee S.J., Kalvakolanu I., Ransohoff R.M., Benveniste E.N. (1996) Stimulus-specific inhibition of intracellular adhesion molecule-1 gene expression by TGF-beta. J. Immunol. 157:892-900.
Spengler R.N., Chensue S.W., Giacherio D.A., Blenk N., Kunkel S.L. (1994) Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J. Immunol. 152:3024-3031.
Stalder M., Phinney A., Probst A., Sommer B., Staufenbiel M., Jucker M. (1999) Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am. J. Pathol. 154:1673-1684.
Steffen B.J., Breier G., Butcher E.C., Schulz M., Engelhardt B. (1996) ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am. J. Pathol. 148:1819-1838.
Szabo C., Hasko G., Zingarelli B., Nemeth Z.H., Salzman A.L., Kvetan V., Pastores S.M., Vizi E.S. (1997) Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide produciton and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology 90:95-100.
Thastrup O., Knudsen J.B., Lemmich J., Winther K. (1985) Inhibition of human platelet aggregation by dihydropy. Biochem. Pharmacol. 34:2137-2140.
Van Eldik L.J. (2001) Glia and Alzheimer's disease. Neurochem. Int. 39:329-331.
Van Eldik L.J., Akama K.T., Krafft G.A., Hu J. (1996) Amyloid-beta peptide activates cultured glia: Cytokine induction and nitric oxide release. Mol. Biol. Cell 7:1033-1033.
Vizi E.S., Lendvai B. (1999) Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res. Rev. 30:219-235.
Vizi E.S., Orso E., Osipenko O.N., Hasko G., Elenkov I.J. (1995) Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience 68:1263-1276.
Vodovotz Y., Lucia M.S., Flanders K.C., Chesler L., Xie Q.W., Smith T.W., Weidner J., Mumford R., Webber R., Nathan C., Roberts A.B., Lippa C.F., Sporn M.B. (1996) Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Medicine 184:1425-1433.
Weber F., Meinl E., Aloisi F., Nevinny-Stickel C., Albert E., Wekerle H., Hohlfeld R. (1994) Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis. Brain 117(PART 1):59-69.
Wegiel J., Wang K.C., Imaki H., Rubenstein R., Wronska A., Osuchowski M., Lipinski W.J., Walker L.C., LeVine H. (2001) The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol. Aging 22:49-61.
White S.R., Bhatnagar R.K., Bardo M.T. (1983) Norepinephrine depletion in the spinal cord gray matter of rats with experimental allergic encephalomyelitis. J. Neurochem. 40:1771-1773.
Wiegmann K., Muthyala S., Kim D.H., Arnason B.G., Chelmicka-Schorr E. (1995) Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J. Neuroimmunol. 56:201-206.
Wilcock G.K., Esiri M.M., Bowen D.M., Hughes A.O. (1988) The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type. J. Neurol. Neurosurg. Psychiatry 51:842-849.
Willenborg D.O., Staykova M.A., Cowden W.B. (1999) Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review. J. Neuroimmunol. 100:21-35.
Willis S.A., Nisen P.D. (1995) Inhibition of lipopolysaccharide-induced IL-1 beta transcription by cyclic adenosine monophosphate in human astrocytic cells. J. Immunol. 154:1399-1406.
Xie Q.W., Kashiwabara Y., Nathan C. (1994) Role of transcription factor NF kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705-4708.
Xie Q.W., Whisnant R., Nathan C. (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Medicine 177:1779-1784.
Zeinstra E., Wilczak N., De Keyser J. (2000) [3H]dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain. Neurosci. Lett. 289:75-77.
Zeinstra E., Wilczak N., Streefland C., De Keyser J. (2000) Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules. Neuroreport 11:89-91.
Zheng Y.M., Schafer M.K., Weihe E., Sheng H., Corisdeo S., Fu Z.F., Koprowski H., Dietzschold B. (1993) Severity of neurological signs and degree of inflammatory lesions in the brains of rats with borna disease correlate with the induction of nitric oxide synthase. J. Virol. 67:5786-5791.
Zoukos Y., Thomaides T., Mathias C.J., Cuzner M.L. (1994) High beta-adrenoceptor density on peripheral blood mononuclear cells in progressive multiple sclerosis: A manifestation of autonomic dysfunction?. Acta Neurol. Scand. 90:382-387.
